Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biogen Spooks With Phase III Aducanumab Changes
Feb 15 2018
•
By
John Davis
Loss of cognition is often seen in Alzheimer's disease patients • Source: Shutterstock
More from Neurological
More from Therapeutic Category